Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 58 Neoplasms 51 Lung Neoplasms 33 Colorectal Neoplasms 28 Carcinoma, Non-Small-Cell Lung 25 Prostatic Neoplasms 22 Melanoma 19 Pancreatic Neoplasms 17 Ovarian Neoplasms 16 Uterine Cervical Neoplasms 14 Sarcoma 12 Multiple Myeloma 12 Lymphoma 11 Glioma 11 Glioblastoma 11 Neoplasm Metastasis 10 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 10 Neoplastic Cells, Circulating 9 Hematologic Neoplasms 9 Lymphoma, Follicular 8 Head and Neck Neoplasms 8 Carcinoma, Hepatocellular 8 Leukemia 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Papillomavirus Infections 6 Myelodysplastic Syndromes 6 Disease 6

Interventions

Doxorubicin 18 Ifosfamide 13 Radiotherapy 8 Paclitaxel 7 pazopanib 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Etoposide 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 trebananib 2 regorafenib 2 cixutumumab 2 cemiplimab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangiosarcoma × Blood Specimen Collection × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡